Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy (Q38056065)

27 August 2017

Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy (English)

1 reference

27 August 2017

0 references

Jong-Hee Kim

1

1 reference

27 August 2017

Hyo-Bum Kwak

series ordinal

2

1 reference

27 August 2017

LaDora V Thompson

series ordinal

3

1 reference

27 August 2017

John M Lawler

series ordinal

4

1 reference

27 August 2017

28 October 2012

1 reference

Journal of Muscle Research & Cell Motility

27 August 2017

1 reference

27 August 2017

34

1 reference

27 August 2017

1

1 reference

27 August 2017

1-13

1 reference

https://scigraph.springernature.com/pub.10.1007/s10974-012-9330-9

27 August 2017

0 references

cites work

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Calcium and the damage pathways in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The pathological damage in Duchenne muscular dystrophy may be due to increased intracellular OXY-radical generation caused by the absence of dystrophin and subsequent alterations in Ca2+ metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Eccentric contraction injury in dystrophic canine muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Integrin-mediated muscle cell spreading. The role of protein kinase c in outside-in and inside-out signaling and evidence of integrin cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin mutations predict cellular susceptibility to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Pharmacologic and genetic therapy for childhood muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Redox signaling across cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Caveolae and caveolin-3 in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The growing role of noninvasive ventilation in patients requiring prolonged mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Imatinib attenuates skeletal muscle dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Duchenne muscular dystrophy: survival by cardio-respiratory interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nitric oxide: biologic effects on muscle and role in muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nuclear factor-kappaB: its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin immunity in Duchenne's muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Association of neuronal nitric oxide synthase (nNOS) with alpha1-syntrophin at the sarcolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Animal models of muscular dystrophy – what can they teach us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Differential association of syntrophin pairs with the dystrophin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Oxidative stress and disuse muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Oxidative stress and the pathogenesis of muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Patients with dystrophinopathy show evidence of increased oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Treatment of Duchenne's muscular dystrophy with penicillamine. Results of a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Apoptosis of skeletal muscles during development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Increased catalase expression improves muscle function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Do immune cells promote the pathology of dystrophin-deficient myopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Drug trial of superoxide dismutase in Duchenne's muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The role of free radicals in the pathophysiology of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Compartmentalization of redox signaling through NADPH oxidase-derived ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

On the classification, natural history and treatment of the myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Targeting fibrosis in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Free radical generation by skeletal muscle of adult and old mice: effect of contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10974-012-9330-9

Duchenne muscular dystrophy

21 January 2018

1 reference

12 December 2020

Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state

1 reference

12 December 2020

Oxidative damage to muscle protein in Duchenne muscular dystrophy

1 reference

12 December 2020

Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse

1 reference

12 December 2020

Materials fatigue initiates eccentric contraction-induced injury in rat soleus muscle

1 reference

12 December 2020

Duchenne muscular dystrophy

1 reference

12 December 2020

Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E

1 reference

12 December 2020

Oxyradical damage and mitochondrial enzyme activities in the mdx mouse

1 reference

12 December 2020

Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old

1 reference

12 December 2020

Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice

1 reference

12 December 2020

Modulation of the dystrophin-associated protein complex in response to resistance training in young and older men

1 reference

12 December 2020

Markers of degeneration and regeneration in Duchenne muscular dystrophy

1 reference

12 December 2020

The capacity of mdx mouse diaphragm muscle to do oscillatory work

1 reference

12 December 2020

Clinical trial of high dosage vitamin E in human muscular dystrophy

1 reference

12 December 2020

The expression of alpha-dystrobrevin and dystrophin during skeletal muscle regeneration

1 reference

12 December 2020

Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells

1 reference

12 December 2020

Involvement of CAPON and nitric oxide synthases in rat muscle regeneration after peripheral nerve injury

1 reference

12 December 2020

Ultrastructural localization of alpha 1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relation to each other and to dystrophin

1 reference

12 December 2020

Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice

1 reference

12 December 2020

Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age.

1 reference

12 December 2020

Muscle cells from mdx mice have an increased susceptibility to oxidative stress

1 reference

12 December 2020

Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice

1 reference

12 December 2020

Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival

1 reference

12 December 2020

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

1 reference

12 December 2020

Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.

1 reference

12 December 2020

Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice

1 reference

12 December 2020

Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species

1 reference

12 December 2020

Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy

1 reference

12 December 2020

mdx muscle pathology is independent of nNOS perturbation

1 reference

12 December 2020

Curcumin alleviates dystrophic muscle pathology in mdx mice

1 reference

12 December 2020

Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.

1 reference

12 December 2020

Duchenne Muscular Dystrophy: Functional Ischemia Reproduces Its Characteristic Lesions

1 reference

12 December 2020

T-cell-dependent fibrosis in the mdx dystrophic mouse

1 reference

12 December 2020

Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy

1 reference

12 December 2020

Tocopherol Deficiency in Man

1 reference

12 December 2020

Amplification of proinflammatory phenotype, damage, and weakness by oxidative stress in the diaphragm muscle of mdx mice

1 reference

12 December 2020

1 reference

12 December 2020

Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice

1 reference

12 December 2020

10.1007/S10974-012-9330-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference